119 related articles for article (PubMed ID: 15930166)
1. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.
Grimaud E; Soubigou L; Couillaud S; Coipeau P; Moreau A; Passuti N; Gouin F; Redini F; Heymann D
Am J Pathol; 2003 Nov; 163(5):2021-31. PubMed ID: 14578201
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma and bone resorption.
Lau YS; Sabokbar A; Giele H; Cerundolo V; Hofstetter W; Athanasou NA
Br J Cancer; 2006 May; 94(10):1496-503. PubMed ID: 16641914
[TBL] [Abstract][Full Text] [Related]
3. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.
Abu-Amer Y
J Clin Invest; 2001 Jun; 107(11):1375-85. PubMed ID: 11390419
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.
Zhang J; Dai J; Qi Y; Lin DL; Smith P; Strayhorn C; Mizokami A; Fu Z; Westman J; Keller ET
J Clin Invest; 2001 May; 107(10):1235-44. PubMed ID: 11375413
[TBL] [Abstract][Full Text] [Related]
5. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
Kawai T; Matsuyama T; Hosokawa Y; Makihira S; Seki M; Karimbux NY; Goncalves RB; Valverde P; Dibart S; Li YP; Miranda LA; Ernst CW; Izumi Y; Taubman MA
Am J Pathol; 2006 Sep; 169(3):987-98. PubMed ID: 16936272
[TBL] [Abstract][Full Text] [Related]
6. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.
Qiang YW; Chen Y; Stephens O; Brown N; Chen B; Epstein J; Barlogie B; Shaughnessy JD
Blood; 2008 Jul; 112(1):196-207. PubMed ID: 18305214
[TBL] [Abstract][Full Text] [Related]
7. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.
Cenci S; Weitzmann MN; Roggia C; Namba N; Novack D; Woodring J; Pacifici R
J Clin Invest; 2000 Nov; 106(10):1229-37. PubMed ID: 11086024
[TBL] [Abstract][Full Text] [Related]
8. Role of Iron Accumulation in Osteoporosis and the Underlying Mechanisms.
Li GF; Gao Y; Weinberg ED; Huang X; Xu YJ
Curr Med Sci; 2023 Aug; 43(4):647-654. PubMed ID: 37326889
[TBL] [Abstract][Full Text] [Related]
9. Oligomeric proanthocyanidins ameliorates osteoclastogenesis through reducing OPG/RANKL ratio in chicken's embryos.
Yu G; Fu X; Gong A; Gu J; Zou H; Yuan Y; Song R; Ma Y; Bian J; Liu Z; Tong X
Poult Sci; 2024 Mar; 103(6):103706. PubMed ID: 38631227
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-level laser therapy on bisphosphonate-treated osteoblasts.
Shin SH; Kim KH; Choi NR; Kim IR; Park BS; Kim YD; Kim UK; Kim CH
Maxillofac Plast Reconstr Surg; 2016 Dec; 38(1):48. PubMed ID: 27995121
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid inhibits TNF-alpha-induced apoptosis in human bone marrow stromal cells.
Byun CH; Koh JM; Kim DK; Park SI; Lee KU; Kim GS
J Bone Miner Res; 2005 Jul; 20(7):1125-35. PubMed ID: 15940365
[TBL] [Abstract][Full Text] [Related]
12. Bone Formation and Maintenance in Oral Surgery: The Decisive Role of the Immune System-A Narrative Review of Mechanisms and Solutions.
Choukroun E; Parnot M; Surmenian J; Gruber R; Cohen N; Davido N; Simonpieri A; Savoldelli C; Afota F; El Mjabber H; Choukroun J
Bioengineering (Basel); 2024 Feb; 11(2):. PubMed ID: 38391677
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in bone remodeling: role of antioxidants.
Domazetovic V; Marcucci G; Iantomasi T; Brandi ML; Vincenzini MT
Clin Cases Miner Bone Metab; 2017; 14(2):209-216. PubMed ID: 29263736
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases.
Callaway DA; Jiang JX
J Bone Miner Metab; 2015 Jul; 33(4):359-70. PubMed ID: 25804315
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and gamma radiation-induced cancellous bone loss with musculoskeletal disuse.
Kondo H; Yumoto K; Alwood JS; Mojarrab R; Wang A; Almeida EA; Searby ND; Limoli CL; Globus RK
J Appl Physiol (1985); 2010 Jan; 108(1):152-61. PubMed ID: 19875718
[TBL] [Abstract][Full Text] [Related]
16. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
[TBL] [Abstract][Full Text] [Related]
17. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
Nakashima T; Kobayashi Y; Yamasaki S; Kawakami A; Eguchi K; Sasaki H; Sakai H
Biochem Biophys Res Commun; 2000 Sep; 275(3):768-75. PubMed ID: 10973797
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
19. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
